Back to discover
Disease
Central Serous Chorioretinopathy
Late-stage therapeutic developmentEmerging research
1
Publications
13
Clinical trials
2022
Latest publication
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this disease.
Research2021-05-21Progress in retinal and eye research
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
No activity recorded in this window. Try a wider timeframe.
Clinical trials
The current development programme across all trial phases.
Clinical programme
13
0
2
6
Late-stage studies
Recently completed
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Most influential
Major themes2
- Central Serous Chorioretinopathy1
- Choroid Diseases1
Leading journals1
- Progress in retinal and eye research1
Leading researchers8
- Behar-Cohen F1
- Boon CJF1
- Brown DM1
- Chhablani J1
- Gemmy Cheung CM1
- Hartnett ME1
- Iida T1
- Kishi S1
Affiliations (unnormalised)6
- Clinical Research Department1
- Gunma University Graduate School of Medicine1
- Institute of Molecular and Clinical Ophthalmology Basel1
- John A. Moran Eye Center1
- Leiden University Medical Center1
- Maebashi Central Eye Clinic1
Reference
Authoritative identity, definition & identifiers.
Defined in MeSH
A visual impairment characterized by the accumulation of fluid under the retina through a defect in the retinal pigment epithelium.
Identifiers
References & data sources
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.